Simon Cocklin, Ph.D. Email & Phone Number

Mars, Pa, Us

Sevenoaks, Gb

As the 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗔𝗱𝘃𝗶𝘀𝗼𝗿 𝗳𝗼𝗿 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 at a nascent therapeutic biotech start-up, I leverage over 20 years of scientific expertise to guide the company’s vision and strategic initiatives, including securing funding and establishing our presence in the biotechnology landscape. My stealth mode role encompasses:✅ 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗢𝘃𝗲𝗿𝘀𝗶𝗴𝗵𝘁: Leading the formulation and execution of 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 to position our nascent therapeutic discovery biotech for success in the competitive market.✅ 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴: Building relationships with 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝗮𝗻𝗱 𝘀𝘁𝗮𝗸𝗲𝗵𝗼𝗹𝗱𝗲𝗿𝘀 to 𝗲𝗻𝗵𝗮𝗻𝗰𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗰𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 and funding opportunities.✅ 𝗘𝘅𝗽𝗲𝗿𝗶𝗺𝗲𝗻𝘁𝗮𝗹 𝗗𝗲𝘀𝗶𝗴𝗻: Advising on the design and implementation of 𝗸𝗲𝘆 𝗲𝘅𝗽𝗲𝗿𝗶𝗺𝗲𝗻𝘁𝘀 to validate 𝗰𝘂𝘁𝘁𝗶𝗻𝗴-𝗲𝗱𝗴𝗲 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀 𝗮𝗻𝗱 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀.✅ 𝗕𝗿𝗮𝗻𝗱𝗶𝗻𝗴 𝗮𝗻𝗱 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻𝗶𝗻𝗴: Contributing to 𝗯𝗿𝗮𝗻𝗱𝗶𝗻𝗴 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲𝘀 that accurately reflect the company's mission and vision, enhancing 𝗺𝗮𝗿𝗸𝗲𝘁 𝘃𝗶𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆 and stakeholder engagement.

Sevenoaks, Gb

Leveraging specialized knowledge and experience to provide strategic advice and scientific guidance to a nascent biotech startup. Focused on shaping the company’s early-stage direction and helping to navigate critical decisions in research and development.✅ 𝗣𝗿𝗼𝘃𝗶𝗱𝗲 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗮𝗱𝘃𝗶𝗰𝗲 𝗮𝗻𝗱 𝗴𝘂𝗶𝗱𝗮𝗻𝗰𝗲, driving key decisions in AI-driven drug discovery.✅ 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗲 𝘄𝗶𝘁𝗵 𝗹𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 to shape early-stage direction and accelerate company growth.✅ 𝗣𝗹𝗮𝘆𝗲𝗱 𝗮 𝗸𝗲𝘆 𝗿𝗼𝗹𝗲 in securing the s𝘁𝗮𝗿𝘁𝘂𝗽’𝘀 𝗮𝗰𝗰𝗲𝗽𝘁𝗮𝗻𝗰𝗲 into a 𝗽𝗿𝗲𝘀𝘁𝗶𝗴𝗶𝗼𝘂𝘀 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗼𝗿, enhancing its resources and network.✅ 𝗗𝗲𝘃𝗲𝗹𝗼𝗽 𝗮𝗻𝗱 𝗿𝗲𝗳𝗶𝗻𝗲 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲𝘀, ensuring alignment with long-term goals.✅ 𝗦𝘂𝗽𝗽𝗼𝗿𝘁 𝗶𝗻 𝗼𝗽𝘁𝗶𝗺𝗶𝘇𝗶𝗻𝗴 𝗿𝗲𝘀𝗼𝘂𝗿𝗰𝗲 𝗮𝗹𝗹𝗼𝗰𝗮𝘁𝗶𝗼𝗻 to maximize impact and efficiency.

Abu Dhabi, Ae

Recently joined 𝘾𝙖𝙣𝙘𝙚𝙧 𝙄𝙢𝙢𝙪𝙣𝙤𝙡𝙤𝙜𝙮 𝘾𝙤𝙣𝙣𝙚𝙘𝙩 as Regional Editor for North America. In this role, I will curate and select research content, including articles and reviews, from North America to ensure the journal reflects the most cutting-edge discoveries in cancer immunology. Additionally, I will maintain the diversity of the journal’s Editorial Board by recruiting experts in the field and contributing to thematic issues on emerging trends in cancer immunology.✅ 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗖𝘂𝗿𝗮𝘁𝗶𝗼𝗻: Plan to select impactful research articles, reviews, and contributions from my geographic region to ensure the journal remains a leading source of innovation.✅ 𝗗𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗮𝗻𝗱 𝗥𝗲𝗰𝗿𝘂𝗶𝘁𝗺𝗲𝗻𝘁: Will actively recruit and maintain a diverse, expert Editorial Board to reflect the wide range of expertise in the field.✅ 𝗧𝗵𝗲𝗺𝗮𝘁𝗶𝗰 𝗝𝗼𝘂𝗿𝗻𝗮𝗹 𝗖𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻𝘀: Expected to contribute or solicit at least one thematic journal issue focusing on emerging and critical areas of cancer immunology research.If you are conducting cutting-edge research in cancer immunology or are interested in joining the Editorial Board, feel free to connect!

Co-founder of Bespoke Patient Solutions LLC, alongside CEO Crystal Kelly. Co-creating the Pocket Patient Advocate (PPA) app and leading its development and strategic planning. Focused on driving innovation in digital healthcare, we aim to transform complex medical information into user-friendly, accessible content. Currently collaborating with cross-functional teams to prepare the app for launch, ensuring its future growth and success. Our mission is to create solutions that address healthcare disparities and improve patient outcomes through technology.✅ 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: Co-creating the Pocket Patient Advocate (PPA), an AI-driven app designed to simplify medical communication between patients and healthcare providers.✅ 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽: Leading product development, alongside Crystal Kelly, to align with future market needs, driving scalability and long-term success.✅ 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 & 𝗚𝗿𝗼𝘄𝘁𝗵: Working closely with development teams to enhance user experience and functionality, positioning PPA to become a leader in digital health.✅ 𝗔𝗹𝘁𝗿𝘂𝗶𝘀𝘁𝗶𝗰 𝗠𝗶𝘀𝘀𝗶𝗼𝗻: Committed to improving healthcare access and outcomes, with a focus on patient empowerment and addressing healthcare inequality.

Innovative scientist with extensive experience in therapeutic discovery and characterization, I am seeking new opportunities in the biotechnology sector around the director level. My career spans academia and industry, with a proven track record of leading successful therapeutic research projects and developing novel methods in drug discovery.✅𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲: Experience with small molecules, biologics, and antibodies. Implemented multiple novel inhibitor discovery projects.✅𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩: Established and managed preclinical drug discovery projects, collaborating effectively with academic institutions and CROs.✅𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐄𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞: Renowned for high-quality research in HIV-1 virology, cancer biology, therapeutic antibodies, and biophysics. Skilled in surface plasmon resonance (SPR) interaction analysis and screening.✅𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐏𝐚𝐭𝐞𝐧𝐭𝐬: Authored over 70 peer-reviewed articles. Maintain an h-index of 33 and an i10-index of 58.✅𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐏𝐫𝐨𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲: Skilled in advanced techniques for drug discovery, including SPR kinetic assays and functional screening. Competent in Cresset, SeeSAR, StarDrop, and Schrödinger software.✅𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐚𝐧𝐝 𝐌𝐞𝐧𝐭𝐨𝐫𝐬𝐡𝐢𝐩: Managed diverse teams of scientists, mentored emerging researchers, and drove projects to surpass research milestones.✅𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐁𝐚𝐜𝐤𝐠𝐫𝐨𝐮𝐧𝐝: Ph.D. in Molecular Genetics from the University of Newcastle Upon Tyne, UK, with postdoctoral research at Drexel University and the University of Pennsylvania.My passion for uncovering next-generation therapeutics and my commitment to rigorous scientific methodology position me as a valuable asset to any biotech firm. I am eager to bring my expertise and innovative thinking to a dynamic team dedicated to transforming scientific research into impactful medical solutions.

As an independent consultant with over 25 years of experience in Surface Plasmon Resonance (SPR) and therapeutic discovery, I provide expert guidance to biotech, pharmaceutical, and academic clients. My services focus on:✅ 𝗦𝗣𝗥 𝗔𝘀𝘀𝗮𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻: Designing and optimizing SPR assays to meet specific research objectives, ensuring accurate data generation and enhanced reproducibility.✅ 𝗦𝗣𝗥 𝗗𝗮𝘁𝗮 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝗻𝗱 𝗜𝗻𝘁𝗲𝗿𝗽𝗿𝗲𝘁𝗮𝘁𝗶𝗼𝗻: Offering deep insights into binding kinetics, including association/dissociation rates and affinities, to support decision-making in therapeutic development.✅ 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗶𝗻𝗴: Leveraging my expertise across HIV, cancer, and infectious diseases to advise on integrating SPR data into broader drug discovery efforts, helping to advance promising candidates through preclinical development.With a proven track record of impactful research, extensive peer-reviewed publications, and patents, I am committed to delivering actionable insights and high-quality outcomes that drive innovative therapeutic solutions.

Santa Fe, New Mexico, Us

Transitioned seamlessly from academia to industry/CRO, specializing in antibody therapeutic discovery and characterization. Delivered comprehensive, end-to-end support across assay development, execution, analysis, and reporting for SPR kinetic assays, agonist/antagonist assays, functional screening, and protein characterization.✅ 𝗣𝗼𝗹𝗶𝗰𝘆 & 𝗣𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁: Spearheaded the development of detailed policies, procedures, and SOPs for SPR experiments, ensuring the highest quality and accuracy in data metrics.✅ 𝗗𝗮𝘁𝗮 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 & 𝗖𝗹𝗶𝗲𝗻𝘁 𝗦𝘂𝗽𝗽𝗼𝗿𝘁: Conducted in-depth data analysis to drive client decision-making in antibody lead selection, supporting multiple discovery programs concurrently.✅ 𝗖𝗿𝗼𝘀𝘀-𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻: Collaborated with cross-functional scientific and project management teams to guarantee timely and budget-conscious project delivery.✅ 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 & 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽: Maintained cutting-edge expertise in antibody discovery and bioanalytical technologies, leading laboratory enhancements and innovations in the bioanalytical group.✅ 𝗣𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵: Published 12 peer-reviewed papers focused on small molecule discovery and therapeutic antibodies.✅ 𝗔𝘀𝘀𝗮𝘆 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻: Adapted an ELISA polyreactivity assay to an SPR format (Carterra and Biacore), automating the assessment of antibody developability and identifying candidates for therapeutic development

Philadelphia, Pennsylvania, Us

Oversaw and led grant development within biochemical and molecular research, and university-and federal-level programs, generating investments in research of up to $2MM.✅Authored 23 peer-reviewed publications documenting innovative multidisciplinary research since being appointed to this role in 2017.✅Successfully demonstrated proof-of-concept of an innovative liganding protocol to generate a novel HIV-1 broadly neutralizing scFv from recombinant, soluble Env SOSIP trimer via phage display.✅Designed a first-in-class drug-like inhibitor of the HIV-1 matrix protein with a novel mechanism of action.✅Designed and tested targeted protein degraders (PROTAC) to direct the proteolytic degradation of HIV-1 proteins.✅Initiated multiple successful inhibitor discovery campaigns identifying and designing compounds to SARS-CoV-2 (https://drexel.edu/functional-fabrics/news/overview/2020/May/Numerous-Drexel-urgent-action-research-teams-working/), Ebola, and cancer targets.

Philadelphia, Pennsylvania, Us

✅Earned tenure-track status and displayed a continued commitment to furthering the institution's level of research and scientific discovery.✅ Delineated the role of a small Rab GTPase in the HIV lifecycle.✅Oversaw and managed collaborative efforts to boost research and support the development of new research programs across the university. By leveraging an extensive network of professionals and scientists with the research efforts of young scientists, faculty, and staff, unparalleled research endeavors throughout the organization were facilitated. ✅Served as the leader of research grants, securing $450k as Principal Investigator. Additionally, supported learner development and success, conducting peer-reviewed publications and presentations at national meetings.✅ Successfully learned and used commercial CADD products and good relationships with their vendors e.g., Cresset, Schrodinger, Optibrium, and BioSolveIT, in drug design projects.

Philadelphia, Pennsylvania, Us

Promoted within the organization to take on a new role, designing a brand-new research area for the department within HIV research. Utilized data-driven metrics, research, analytics, and insight within research and development to secure grants funding proposed work. Additionally, taught, developed, and mentored graduates and undergraduates supporting advancements in biochemistry research.

Philadelphia, Pennsylvania, Us

Participated in a prestigious, multi-institutional, cross-disciplinary group focused on understanding and inhibiting HIV-1 entry into cells using peptides, chemically augmented peptides, and mini-proteins.

Philadelphia, Pennsylvania, Us

Participated in a prestigious, multi-institutional, cross-disciplinary group focused on understanding and inhibiting HIV-1 entry into cells using peptides, chemically augmented peptides, and mini-proteins.

Philadelphia, Pa, Us

Participated in a prestigious, multi-institutional, cross-disciplinary group focused on understanding and inhibiting HIV-1 entry into cells using peptides, chemically augmented peptides, and mini-proteins. Developed novel SPR assays, including reconstitution of an active GPCR in lipid/detergents on sensor surface.

Newcastle Upon Tyne, Tyne And Wear, Gb

Used biophysics (SPR and ITC) to gain insight into the macromolecular interactions (protein [GATA-type transcription factor and repressor protein], nucleic acid, metabolite) involved in the regulation of a global gene expression circuit in 𝐴𝑠𝑝𝑒𝑟𝑔𝑖𝑙𝑙𝑢𝑠 𝑛𝑖𝑑𝑢𝑙𝑎𝑛𝑠.

Doctor Of Philosophy - Phd, Molecular Genetics

Bachelor Of Science - Bs, Molecular Genetics